Moleculin Biotech, Inc. (NASDAQ:MBRX) Q3 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Moleculin Biotech Quarterly Update Conference Call and Webcast. At this time, all participants are in listen only mode.
Metabasis Therapeutics Inc (MBRX)
Market is closed
Sector: Pharmaceutical Preparations
News See All
Moleculin Biotech, Inc. (NASDAQ:MBRX) Q1 2024 Earnings Call Transcript
Operator: Hello, and welcome to the Moleculin Biotech first quarter 2024 quarterly update conference call and webcast. A question-and-answer session will follow the formal presentation.
Moleculin Biotech, Inc. (NASDAQ:MBRX) Q4 2023 Earnings Call Transcript
Operator: Greetings, welcome to the Moleculin Biotech 2023 Year-End Conference Call and Webcast. [Operator Instructions] Please note, that this conference is being recorded.
Moleculin Biotech, Inc. (NASDAQ:MBRX) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Moleculin Biotech Third Quarter 2023 Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
Moleculin Biotech, Inc. (NASDAQ:MBRX) Q2 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Moleculin Biotech Quarterly Update Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
Moleculin Biotech, Inc. (NASDAQ:MBRX) Q1 2023 Earnings Call Transcript
Operator: Hello and welcome to the Moleculin Biotech Q1 2023 Quarterly Update Conference Call and Webcast. A question-and-answer session will follow the formal presentation.
Moleculin Biotech, Inc. (NASDAQ:MBRX) Q4 2022 Earnings Call Transcript
Operator: Hello and welcome to the Moleculin Biotech Fiscal Year 2022 Quarterly Update Conference Call and Webcast. A question-and-answer session will follow the formal presentation.
13G Filing: Sabby Capital and Moleculin Biotech Inc (MBRX)
Sabby Healthcare Master Fund, Ltd | 0 | 0 | 0 | 0 | 0 | 0 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 60855D101 1. NAME OF REPORTING PERSONS Sabby Volatility Warrant Master Fund, Ltd.
Moleculin Biotech Inc (MBRX): Proceed With Caution
Moleculin Biotech Inc (NASDAQ:MBRX), an oncology-focused pharmaceutical firm that just joined public markets in June, is making some waves in the biotech world.
Billionaire Hedge Funds
